Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
about
Use of VacA as a Vaccine AntigenPrimary Antibiotic Resistance of Helicobacter pylori in China.Treatment of Helicobacter pylori infection: Where are we now?Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Characterization in Helicobacter pylori of a Nickel Transporter Essential for Colonization That Was Acquired during Evolution by Gastric Helicobacter Species.Helicobacter pylori therapy: a paradigm shift.Helicobacter pylori eradication in the Swedish population.Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection.Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best.Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori.The diagnosis and management of H. pylori infection in Singapore.Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival.Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin.Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication.Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials.Dealing with uncertainty in the treatment of Helicobacter pylori.Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.Outcomes of furazolidone- and amoxicillin-based quadruple therapy for infection and predictors of failed eradication
P2860
Q26747436-B837C242-A9A4-4112-B270-34EBB0A8EA80Q30235219-10DCDB89-91EF-4165-98AA-93B0C0F49787Q30251567-7432713A-5470-41AA-9F66-E0073000C9C8Q33562959-B80C951F-A390-4816-B50E-84B295B7D365Q33639114-2FA91B6C-1442-4018-A46F-332EC3615A71Q36214292-6FBC57F2-972C-4F20-ACE2-7C500C033D92Q37082187-30DC8BF1-11BB-4105-B208-6F48623011B6Q38402111-068473A5-3AEC-4667-A28D-509CBE09B67DQ38630807-431167BB-3022-4E6A-9B01-5A2150249983Q38747268-14AAFBF9-0EDC-42C3-B281-332ABE14ED85Q38846038-33AAB6A5-8FC2-4A7E-926E-7F743B1DE2CDQ39496571-8C78A631-2C02-4D6E-BFBA-A8EC66372CC4Q40067953-B83D462D-9D7A-4094-BC26-6946DC921573Q40088872-B3D99A27-05FE-48DF-8B27-E7282B541CF1Q40167790-3017A201-DD17-4129-A68C-956816E02832Q40201360-7E5C510C-130E-4763-ADEC-C316E429179FQ40271049-953E64F1-0BC8-49F4-9637-9F1369A0975EQ40502852-3285564C-669C-4B34-A93B-2383CADE2270Q40526981-735777FA-8782-49EB-B640-AE2F50B5769FQ42369204-5715E350-96F8-4C2B-A03A-AC2DB030F51AQ47158212-4059E7B9-E501-49D1-83E9-7268A374735DQ47222389-098D3407-EF5C-4572-B50E-71FF7745F465Q47225018-44C7551F-ECFC-40F5-AF88-7B6B5B6787D3Q48543213-F9388AD4-D056-4001-9C94-34CBA16DBB3EQ52330458-2CCCBE20-3BC1-4990-966A-A122FF7BE56BQ53724785-7F1B6BF9-5538-49BE-A3A2-169BED70FB33Q55280909-5A4105ED-0748-4DA9-947B-3786C7505F12Q58602131-99315D10-EA0E-4D05-92D2-B0B12BC3D813
P2860
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
@en
type
label
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
@en
prefLabel
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
@en
P2860
P1433
P1476
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
@en
P2093
Maria Pina Dore
P2860
P304
P356
10.1136/GUTJNL-2015-311019
P407
P577
2016-02-04T00:00:00Z